Expert insights reveal how 3D cellular models are revolutionising preclinical testing and clinical translation.

Explore how Shift Bioscience optimises cell models for gene discovery, enhancing rejuvenation therapies and age-related ...

Explore how MitoRx’s Myo4 is showing promise in combating obesity by restoring insulin sensitivity and reducing fat.

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...

Explore the role of non-human primates in drug development and the ethical challenges associated with their use in research.

Explore new therapeutic targets for leukaemia treatment discovered by researchers in Japan, focusing on acute myeloid ...

A team of scientists at POSTECH have successfully developed a three-dimensional brain model that closely replicates the human brain’s structure and function. Their groundbreaking study was published ...

Under the agreement, Chiesi obtains a worldwide, royalty-bearing license to develop and commercialise two BBB-penetrant ERTs from Key2Brain. These therapies are built on a prior research collaboration ...

Fauna Bio has announced the launch of Fauna Brain, a new AI platform designed to accelerate drug target discovery and streamline early-stage research and development. Building on the company’s ...

This episode, ‘ Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials,’ will explore the challenges and successes of moving promising drug candidates from preclinical ...

DenovAI, an AI-first biotechnology company, has published a new study in Molecular Systems Biology demonstrating the power of its novel de novo protein design tool. The study introduces an advanced AI ...

A team at Southern Medical University has developed a novel self-propelled ferroptosis nanoinducer that significantly improves tumour tissue penetration – one of the biggest hurdles facing ...